Back
Inhibrx Biosciences Vs. IGC Pharma Industry Stock Comparison
Buy
54
INBX
Inhibrx Biosciences
Last Price:
13.96
Seasonality Move:
--
Sell
28
IGC
IGC Pharma
Last Price:
0.36
Seasonality Move:
-9.08%
Buy
54
Inhibrx Biosciences (INBX)
is a Buy
Is Inhibrx Biosciences a Buy, Sell or Hold?
- The current Inhibrx Biosciences [INBX] share price is $14.04. The Score for INBX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- INBX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy, Sell or Hold?
- The current IGC Pharma [IGC] share price is $0.33. The Score for IGC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- IGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INBX Stock Price Chart
What is Inhibrx Biosciences's stock price today?
-
The Inhibrx Biosciences share price today is $14.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INBX is experiencing slight selling pressure.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGC is experiencing selling pressure, which indicates risk of future bearish movement.
INBX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 37.96 | Sell |
Chaikin Money Flow: | -41514 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.71 - 16.33) | Sell |
Bollinger Bands (100): | (13.09 - 16.09) | Sell |
IGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 33.35 | Sell |
Chaikin Money Flow: | -122391 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.36 - 0.4) | Sell |
Bollinger Bands (100): | (0.35 - 0.43) | Sell |
INBX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.77 | Sell |
20-day SMA: | 15.44 | Sell |
50-day SMA: | 15.68 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 14.58 | Sell |
20-day EMA: | 15.15 | Sell |
50-day EMA: | 15.29 | Sell |
200-day EMA: | 2.13 | Buy |
IGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.36 | Sell |
20-day SMA: | 0.38 | Sell |
50-day SMA: | 0.37 | Sell |
200-day SMA: | 0.41 | Sell |
8-day EMA: | 0.35 | Sell |
20-day EMA: | 0.37 | Sell |
50-day EMA: | 0.38 | Sell |
200-day EMA: | 0.39 | Sell |
Inhibrx Biosciences Earnings Growth & INBX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
IGC Pharma Earnings Growth & IGC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.
Inhibrx Biosciences Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IGC Pharma Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |